Table 4.
Sr. no | Drug | Colo 320DM | HT29 | Hella | |||
---|---|---|---|---|---|---|---|
% inhibition | % viability | % inhibition | % viability | % inhibition | % viability | ||
1 | Lycopene | 62.99 ± 0.3253 | 37.82 ± 0.2619 | 57.94 ± 0.6343 | 41.14 ± 0.7760 | 61.25 ± 0.2658 | 38.75 ± 0.3899 |
2 |
Lycopene AgNP |
79.44 ± 0.4967 | 21.28 ± 0.2902 | 88.05 ± 0.1870 | 12.08 ± 0.0946 | 65.47 ± 0.4766 | 36.05 ± 0.7071 |
3 |
Lycopene FeNP |
64.8 ± 0.4172 | 33.93 ± 0.6697 | 67.86 ± 0.2661 | 30.76 ± 0.7734 | 64.76 ± 0.4115 | 35.5 ± 0.4215 |
4 |
Lycopene GNP |
83.45 ± 0.4694 | 16.31 ± 0.3922 | 80.72 ± 0.8134 | 18.74 ± 0.4422 | 57.51 ± 0.4805 | 42.4 ± 0.6191 |
Values are expressed in triplicate mean ± SD